Active	Status	Sponsor type	Region	Phase	Filter
22 Active 6 Inactive 28 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Paiella, Salvatore
NCT06026943: Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer	Not yet recruiting	N/A	15	NA	DaRT seeds insertion, Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)	Alpha Tau Medical LTD.	Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma	01/26	01/28
Malleo, Giuseppe
TRIPP-FFX, NCT05466799: FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma	Recruiting	2	80	Europe, RoW	FOLFIRINOX chemotherapy, Folinic Acid, 5-FU, Oxaliplatin, Irinotecan, OncoSil™, Phosphorous-32 microparticles	OncoSil Medical Limited	Locally Advanced Pancreatic Cancer	06/25	09/25
Cattelani, Alice
No trials found